ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 168 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,542,653 | +251.3% | 1,574,136 | +398.3% | 0.00% | +200.0% |
Q2 2023 | $439,141 | -4.0% | 315,929 | +9.8% | 0.00% | 0.0% |
Q1 2023 | $457,292 | -58.1% | 287,605 | +64.3% | 0.00% | -50.0% |
Q4 2022 | $1,090,393 | -71.0% | 175,023 | -68.8% | 0.00% | -75.0% |
Q3 2022 | $3,758,000 | +2123.7% | 560,987 | +2009.0% | 0.01% | – |
Q2 2022 | $169,000 | -97.3% | 26,600 | -94.9% | 0.00% | -100.0% |
Q3 2021 | $6,268,000 | -74.7% | 520,095 | -55.6% | 0.03% | -76.8% |
Q2 2021 | $24,789,000 | -14.2% | 1,172,070 | +13.8% | 0.11% | -15.2% |
Q1 2021 | $28,882,000 | -19.3% | 1,029,701 | -25.2% | 0.13% | -32.0% |
Q4 2020 | $35,774,000 | -29.5% | 1,375,930 | +0.7% | 0.19% | -40.3% |
Q3 2020 | $50,778,000 | -33.5% | 1,366,105 | -14.1% | 0.32% | -39.3% |
Q2 2020 | $76,336,000 | +82.9% | 1,590,774 | +20.2% | 0.54% | +28.3% |
Q1 2020 | $41,744,000 | +11121.5% | 1,323,947 | +14182.1% | 0.42% | +20750.0% |
Q1 2019 | $372,000 | -62.7% | 9,270 | -23.9% | 0.00% | -84.6% |
Q2 2015 | $996,000 | -90.7% | 12,182 | -89.5% | 0.01% | -90.7% |
Q1 2015 | $10,754,000 | +4555.4% | 116,138 | +1932.9% | 0.14% | +4566.7% |
Q4 2014 | $231,000 | – | 5,713 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 2,818,835 | $59,618,000 | 21.09% |
Bellevue Group AG | 4,519,164 | $95,580,000 | 0.93% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,713,176 | $36,234,000 | 0.84% |
Rhenman & Partners Asset Management AB | 572,267 | $12,103,000 | 0.82% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 64,434 | $1,363,000 | 0.45% |
Boxer Capital, LLC | 500,000 | $10,575,000 | 0.37% |
EMC Capital Management | 27,566 | $583,000 | 0.33% |
WASATCH ADVISORS LP | 3,766,935 | $79,671,000 | 0.32% |
Avidity Partners Management LP | 400,000 | $8,460,000 | 0.23% |
Cinctive Capital Management LP | 186,170 | $3,937,000 | 0.18% |